TIGIT and neoplasm: In murine lung metastasis models, it was shown that IL-15 therapy was more effective in reducing tumor burden when infused with TIGIT-deficient NK cells compared to WT NK cells [141], thus providing evidence that TIGIT blockers, combined with IL-15 therapy and NK cell adoptive transfer, could be an interesting therapeutic strategy.